Related Experiment Video
Updated: Feb 5, 2026
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
The Hypercholesterolemia Paradox in Percutaneous Coronary Intervention: An Analysis of a Multicenter PCI Registry
Daisuke Ueshima1, Shunji Yoshikawa2, Taro Sasaoka1
1Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Japan.
Insights
Hypercholesterolemia (HC) patients showed better outcomes after percutaneous coronary intervention (PCI) with everolimus-eluting stents (EESs). This finding suggests HC may be protective in certain cardiovascular contexts, warranting further investigation.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Research
Background:
- Hypercholesterolemia (HC) is a known cardiovascular risk factor.
- Existing research suggests HC may be associated with lower adverse events in specific patient groups, such as those with cancer or acute coronary syndrome.
- The impact of HC on outcomes after percutaneous coronary intervention (PCI) using everolimus-eluting stents (EESs) requires further clarification.
Purpose of the Study:
- To evaluate the association between hypercholesterolemia (HC) and clinical events in patients undergoing PCI with EESs.
- To compare adverse event rates between HC and non-HC patients within the Tokyo-MD PCI registry.
- To identify potential factors influencing the relationship between HC and outcomes post-PCI.
Main Methods:
- Analysis of data from the Tokyo-MD PCI study, an all-comer, multicenter, observational registry.
- Application of the propensity score method to create matched pairs of HC and non-HC patients with similar baseline characteristics.
- Assessment of primary and secondary composite endpoints, including mortality, myocardial infarction, neurological events, and major bleeding.
Main Results:
- Propensity score matching created 314 well-matched pairs of HC and non-HC patients.
- HC patients demonstrated significantly better outcomes compared to non-HC patients across primary and secondary endpoints.
- Hazard ratios indicated a reduced risk of composite adverse events (HR 0.56) and major bleeding (HR 0.42) in HC patients post-PCI.
Conclusions:
- Hypercholesterolemia (HC) was associated with improved clinical outcomes in patients treated with everolimus-eluting stents (EESs) during PCI.
- The protective association of HC persisted even after adjusting for baseline characteristics using propensity score matching.
- Age was identified as a significant interaction factor influencing the primary endpoint in HC patients undergoing EES implantation.
Abstract:
Objective The aim of this study was to assess the relationship between hypercholesterolemia (HC) and clinical events through a percutaneous coronary intervention (PCI) registry. HC is a well-known independent risk factor for long-term cardiovascular events after PCI. However, it has been reported to be associated with a lower risk of adverse events in patients with cancer or acute coronary syndrome. Methods We analyzed the relationship between HC and adverse events in patients treated with everolimus-eluting stents (EESs) through the Tokyo-MD PCI study (an all-comer, multicenter, observational registry). The propensity score method was applied to select two groups with similar baseline characteristics. Results The unadjusted population included 1,536 HC patients and 330 non-HC patients. Propensity score matching yielded 314 matched pairs. After baseline adjustment, the outcomes of HC patients were significantly better than those of the non-HC patients with respect to the primary endpoint, which was a combination of mortality from all causes, nonfatal myocardial infarction (MI), nonfatal neurological events, and major bleeding [hazard ratio (HR) 0.56, 95% confidence interval (CI) 0.39-0.81; p=0.002], and the secondary endpoints, which included a combination of mortality from all causes, nonfatal MI, and nonfatal neurological events (HR 0.59, 95% CI 0.39-0.88; p=0.01), and major bleeding (HR 0.42, 95% CI 0.20-0.88; p=0.02). A subgroup analysis showed age as an interaction factor for the primary endpoint (interaction p=0.035). Conclusion HC was associated with better outcomes in patients who underwent EES implantation, even after baseline adjustment.
Related Concept Videos
01:03Nursing Interventions I: Taxonomy of Nursing Interventions
A nursing intervention is a treatment or action based on scientific concepts and knowledge from the nursing, behavioral, and physical sciences. Identifying and prioritizing nursing interventions based on the desired outcome...
01:29Nursing Interventions II: Selecting and Classifying the Nursing Interventions
01:21Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
01:30Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
01:24Operant Conditioning Intervention
In operant conditioning, behaviors that are...
01:30Coronary Artery Disease I: Introduction